| 000 | 01034 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514024439.0 | ||
| 264 | 0 | _c20030623 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a1354-3784 | ||
| 024 | 7 |
_a10.1517/13543784.11.3.387 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRusconi, Stefano | |
| 245 | 0 | 0 |
_aHIV-1 protease inhibitors in development. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cMar 2002 |
||
| 300 |
_a387-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aLa Seta Catamancio, Simona | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 11 _gno. 3 _gp. 387-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.11.3.387 _zAvailable from publisher's website |
| 999 |
_c11774393 _d11774393 |
||